It’s been about a week since Omicron (B.1.1.529), a new SARS-CoV-2 variant, was designated a “variant of concern” by the World Health Organization. Researchers around the world are racing to fully understand the potential threats Omicron poses regarding its transmissibility, its virulence and its potential to evade the COVID-19 vaccines. Dr. Monica Gandhi, infectious disease specialist and professor of medicine at the University of California, San Francisco, spoke with Yahoo News on Dec. 2 about a few updates on Omicron and what physicians have seen on the ground in South Africa.

Welcome to Dissenter

The Comment Section of the Internet
There are no comments at this time.
Log In